๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials

โœ Scribed by S. G. Nayfield; P. A. Ganz; C. M. Moinpour; D. F. Cella; B. J. Hailey

Publisher
Springer Netherlands
Year
1992
Tongue
English
Weight
827 KB
Volume
1
Category
Article
ISSN
0962-9343

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Completion rates in health-related quali
Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group
โœ David Osoba; Benny Zee ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB ๐Ÿ‘ 2 views

The approach of the National Cancer Institute of Canada Clinical Trials Group to measuring compliance, that is, completion rates, for health-related quality of life questionnaires is presented. Completion rates can be measured at the institutional, patient, questionnaire and item levels for baseline

Report from the International Union Agai
Report from the International Union Against Cancer (UICC) Tumor Biology Committee : UICC workshop on the use of dendritic cells in cancer clinical trials
โœ Michael L. Salgaller; Martin Thurnher; Georg Bartsch; Alton L. Boynton; Gerald P ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 2 views

Cancer (UICC) Tumor Biology Committee to evaluate the results of dendritic cell-based immunotherapy for cancer patients. Suggested reading about this therapy is listed in the References. [1][2][3][4][5][6][7][8][9][10] The following are the recorded results of the workshop discussions. Individual pr

A postscript to the International Worksh
A postscript to the International Workshop on Assessing Health-related Quality of Life in Children with Cancer
โœ David Feeny; Ronald D. Barr; William Furlong; Melissa Hudson; Raymond Mulhern ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 31 KB ๐Ÿ‘ 3 views

The purpose of this report is to provide a brief summary of discussions that took place at the International Workshop. This report is meant to complement the perspectives provided by the discussants (G. Guyatt, J. Landgraf and B. Pollock) in their reports and in the commentary provided by G.A. Monac

Vorinostat in advanced prostate cancer p
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium
โœ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 163 KB ๐Ÿ‘ 2 views